Indian pharmaceutical stocks surged after the US exempted the sector from new tariffs. The Nifty Pharma index jumped 2.3%, with companies like IPCA Laboratories, Lupin, Sun Pharmaceutical, and Cipla experiencing significant gains. Analysts see growth potential and valuation comfort, suggesting it's a good time to invest, although future tariff possibilities remain.
